Lv1
48 积分 2022-09-16 加入
Dual-target CAR-T cell therapy: A new strategy to improve the therapeutic effect of hematological malignancies
2天前
已完结
Afamitresgene autoleucel: first cell therapy for synovial sarcoma
3天前
已完结
Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors
3天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
10天前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
16天前
已完结
Afamitresgene Autoleucel: First Approval
21天前
已完结
Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial
24天前
已完结
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectiveness
27天前
已完结
Lipid nanoparticle-mediated drug delivery to the brain
1个月前
已完结
Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity
1个月前
已完结
皖公网安备34019202002308
